MaxCyte shares fall as revenue plummets in first half, loss widens
MaxCyte Inc on Thursday reported an increased loss in the first half of 2023, as revenue fell while costs increased.
The Maryland, US-based cell-engineering technology platform...
Thu, 10/08/2023 - 10:22